This site is intended for healthcare professionals
News

Brilinta approved by FDA to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease .-AstraZeneca

Read time: 1 mins
Last updated:2nd Jun 2020
Published:2nd Jun 2020
Condition: Diabetes Type 2 + CV Disease
Type: drug
Register free for full access to medthority.com